首页> 外文期刊>Taiwanese journal of obstetrics and gynecology >Clinical and urodynamic effects of tolterodine in women with an overactive bladder
【24h】

Clinical and urodynamic effects of tolterodine in women with an overactive bladder

机译:托特罗定对膀胱过度活动症女性的临床和尿流动力学影响

获取原文
       

摘要

Objective The aim of this study was to compare the changes in urinary symptoms and urodynamic parameters after administration of tolterodine in women with an overactive bladder (OAB). Materials and Methods Thirty-eight women diagnosed with OAB and treated with tolterodine were reviewed. Urinalysis, pelvic examination, 3-day bladder diary, urodynamic study, and a personal interview to identify urinary symptoms prior to and 3 months after treatment were recorded and interpreted. Results Most of our patients were menopausal (76.3%; mean age 55.7 years) and multiparous (mean parity 3.3) women. Urinary symptoms such as urinary frequency, urgency, urge incontinence, and nocturia were decreased significantly ( p ?
机译:目的本研究的目的是比较给予膀胱过度活动症(OAB)妇女使用托特罗定后,尿路症状和尿动力学参数的变化。材料与方法对38例诊断为OAB并接受托特罗定治疗的妇女进行了回顾。记录并解释尿液分析,骨盆检查,3天膀胱日记,尿流动力学研究以及在治疗前和治疗后3个月进行个人访谈以确定尿液症状。结果我们的大多数患者是更年期(76.3%;平均年龄55.7岁)和多胎(平均胎次3.3)的女性。尿频,尿急,急迫性尿失禁和夜尿症等尿道症状明显减少(p <0.05)。除最大膀胱容量(p≤0.05)外,所有尿动力学参数均未发生明显变化,服药3个月后显示出明显增加。结论尿动力学参数的变化证明,推荐剂量的托特罗定可以改善OAB综合征的症状而不会引起尿retention留。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号